现代医药卫生2024,Vol.40Issue(4) :660-663,670.DOI:10.3969/j.issn.1009-5519.2024.04.024

凝溶胶蛋白在人类癌症中的诊断及调控作用研究进展

Research progress on the diagnosis and regulation of GSN in human cancer

王仡阳 荆宇博 郭晨明
现代医药卫生2024,Vol.40Issue(4) :660-663,670.DOI:10.3969/j.issn.1009-5519.2024.04.024

凝溶胶蛋白在人类癌症中的诊断及调控作用研究进展

Research progress on the diagnosis and regulation of GSN in human cancer

王仡阳 1荆宇博 1郭晨明1
扫码查看

作者信息

  • 1. 新疆医科大学第一附属医院消化血管中心乳腺外科,新疆乌鲁木齐 830011
  • 折叠

摘要

凝溶胶蛋白(GSN)是一种多功能肌动蛋白结合蛋白,通过调节肌动蛋白细胞骨架重组和细胞外基质重塑影响肿瘤细胞的生物学活动.GSN的表达与缺失在不同肿瘤中发挥着双向作用,在多种癌症中GSN可增强肿瘤细胞的增殖、迁移和侵袭能力,促进肿瘤的发生与转移,并且逆转GSN的表达可抑制肿瘤细胞的恶性行为.此外,GSN具有成为多种癌症诊断标志物的潜力,可作为基因特征预测肿瘤患者的预后情况.该文就GSN在人类癌症中的双向调控作用、诊断效用及应用前景进行了综述.

Abstract

Gelsolin(GSN)is a multifunctional actin-binding protein that affects the biological activity of tumor cells by regulating actin cytoskeleton reorganization and extracellular matrix remodeling.The expres-sion and deletion of GSN exhibit a bidirectional effect on various tumors.GSN can enhance the proliferation,migration,and invasion of tumor cells in multiple cancer types,thereby promoting tumor occurrence and me-tastasis.And reversing GSN expression can suppress the malignant behavior of tumor cells.Furthermore,GSN exhibits the potential to serve as a diagnostic marker for diverse types of cancer and may function as a genetic signature to forecast the prognosis of individuals with tumors.This article reviewed the bidirectional regulato-ry function,diagnostic efficacy,and potential applications of GSN in human cancer.

关键词

肿瘤/凝溶胶蛋白/诊断/调控作用/综述

Key words

Tumor/Gelsolin/Diagnosis/Regulation/Review

引用本文复制引用

基金项目

国家自然科学基金地区项目(32260186)

新疆医科大学研究生创新创业项目(XJ2023G169)

出版年

2024
现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
参考文献量38
段落导航相关论文